Overview: Gastrin TestIntroduction: The Gastrin Test measures gastrin levels to diagnose Zollinger-Ellison syndrome or digestive disorders, causing ulcers or abdominal pain. Aligned with 2023 AGA guidelines, it uses an immunoassay for high sensitivity, aiding in digestive screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in endocrinology for patients with suspected digestive disorders.
Other Names: Gastrin Assay, Serum Gastrin Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Gastrin testing began in the 1960s with Zollinger-Ellison syndrome research. Immunoassays emerged in the 1980s, improving accuracy for digestive disorders.
Purpose: Diagnoses Zollinger-Ellison syndrome or digestive disorders, guides treatment, and monitors gastrin levels in patients with ulcers or abdominal pain.
Test Parameters: 1. Gastrin
Pretest Condition: Fasting for 10-12 hours required to stabilize gastrin levels. Collect serum or plasma in the morning. Report symptoms like ulcers or abdominal pain, and list medications.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document ulcers, abdominal pain, or history of digestive disorders. Include current medications, especially proton pump inhibitors.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for treatment.
Procedural Considerations: Uses an immunoassay to measure gastrin levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting, hemolysis, or medications (e.g., PPIs) can affect results. Renal failure may elevate levels.
Clinical Significance: Elevated gastrin levels suggest Zollinger-Ellison syndrome, prompting further testing or treatment. Normal levels may require additional evaluation.
Specialist Consultation: Consult a gastroenterologist for result interpretation.
Additional Supporting Tests: Secretin stimulation test, endoscopy, or imaging to confirm Zollinger-Ellison syndrome.
Test Limitations: Medications like PPIs may elevate levels. Results require clinical correlation.
References: AGA Gastrin Guidelines, 2023; Gastroenterology, Jensen RT, 2022.
